Wednesday, 10 August 2016

What the Defend Trade Secrets Act Means for Intellectual Property

On May 11, 2016, President Obama officially signed the Defend Trade Secrets Act or DTSA, after it had unanimously passed in the Senate and was ratified in the House with a vote of 410 to 2. This created a federal private civil action that allows for the misappropriation of trade secrets. While it does not […]

The post What the Defend Trade Secrets Act Means for Intellectual Property appeared first on Rogers DVS, written by Graham Rogers DVS. http://ift.tt/2bgjwaO



via Tumblr http://ift.tt/2aLQaBl

Arctic Cat Awarded Trebled Damages of $46.7 Million  

Arctic Cat has recently been awarded damages of $46.7 million in its case against Bombardier Recreational Products, Inc. (BRP), an award that is more than triple the $15 million the jury awarded Arctic on June 1st. The judge’s decision to increase the amount of the award was based on the determination that BRP “willfully” infringed […]

The post Arctic Cat Awarded Trebled Damages of $46.7 Million   appeared first on Rogers DVS, written by Graham Rogers DVS. http://ift.tt/2bgiDPB



via Tumblr http://ift.tt/2bfkIIs

Apple vs. Samsung in the Supreme Court

  The fight between Apple Inc. and Samsung Electronics Co., the world’s two leading smartphone manufacturers, is not limited to the marketplace – in the past five years, Apple has filed over fifty patent infringement lawsuits internationally against Samsung. The most recent United States ruling was decided in favor of Apple by the Federal Court […]

The post Apple vs. Samsung in the Supreme Court appeared first on Rogers DVS, written by Graham Rogers DVS. http://ift.tt/2bgiITu



via Tumblr http://ift.tt/2aLQ904

Gilead Sciences Loses 200 Million Dollar Case to Merck

Gilead Sciences is a bio-pharmaceutical research and development company that discovers, develops and commercializes innovative medicines in areas of unmet medical need.  Recently, Gilead lost a patent infringement case to Merck, another pharmaceuticals company, and was ordered to pay $200 million in royalties for a pair of hepatitis C drugs, Sovaldi and Harvoni.  The combined […]

The post Gilead Sciences Loses 200 Million Dollar Case to Merck appeared first on Rogers DVS, written by Graham Rogers DVS. http://ift.tt/2bgiKe4



via Tumblr http://ift.tt/2bflmWb